Page 47 - Sohini Das

Centre moots unified portal for drug regulation to build trust in quality

Move seeks to harmonise regulatory requirements at central and state level

Tata plugs into UK automotive sector for $5.2 bn electric car gigafactory

JLR, Tata Motors to be anchor customers of EV battery unit

Temasek Holdings looking to invest $10 billion in India in 3 years

Temasek, an early investor in Indian firms like Zomato, Tata Play, and Ola, plans to invest in climate-aligned opportunities such as renewable energy and companies engaged in decarbonisation efforts

Temasek investments guided by digitisation, future of consumption: Execs

Country's demographics, steady policy and focus on infrastructure are among its strengths, say senior executives of Singapore-based investment firm

Electric two-wheeler firms cut on battery size after FAME subsidy reduced

Portfolio rejig may keep prices low for customers

Results preview: Price hikes, lower input costs to aid auto firms' Q1

Most auto OEMs have increased their prices in the past few months and analysts feel that higher average selling price on a YoY basis would aid margins

Q1 preview: US drug shortage, stable pricing set to boost pharma revenues

Hospitals are, however, likely to report lower occupancy rates, and diagnostics companies may witness an impact from delayed monsoon

Waiver for rare disease drugs brings little relief: Pharma sector

Industry bats for extending exemption to drugs that are already commercially available in India

Schedule M of Drugs and Cosmetics Act to be made must for all pharma units

Govt wants units to move towards GMP through self regulation

Share of top-end cars in Mercedes' India sales nearly 2x in 5 years

One in four cars sold by Mercedes in India in H1 2023 is priced above Rs 1.5 cr

Wockhardt charting a recovery riding on a promising new antibiotic

While global trials are on, doctors have started using one of company's antibiotics against superbugs to save lives

Robust Jaguar Land Rover sales in June quarter power up Tata Motors

Wholesale, retail volumes up 30% and 29%, respectively

Dr Reddy's Laboratories forays into new terrain to give 'top-5' aim a shot

Analysts think that these new entries may help the company navigate multiple risks in the Indian branded market

Biocon Biologics eyes third of FY24 revenue from emerging markets

BBL, which launched Hulio, a biosimilars version of Abbvie's blockbuster drug Humira, in the US earlier this week, is planning to launch this drug in other countries in the near term

Bajaj-Triumph, Hero-Harley entry shifts premium bike race into top gear

Royal Enfield is also the undisputed leader in the 250cc-350cc segment, virtually owning the market at a whopping 94 per cent share

Biocon Biologics expands to over 70 countries, enters emerging markets

Completes integration of the acquired biosimilars business from Viatris

Biosimilar Humira likely to boost US revenues for Biocon Biologics

Analysts, however, feel that together with upcoming Aspart (insulin) and vaccines, Hulio will help drive BBL's revenues from the current $1 billion to around $1.65 billion by FY25

Stelis sells Bengaluru facility to Biocon arm Syngene for Rs 702 cr

Both parties have entered into a binding term sheet to execute the deal whereby Syngene has acquired the unit 3 facility in Bengaluru for Rs 702 crore

'4IR': The booster pharma majors are taking to improve productivity

Large manufacturers are leveraging new-age technologies and advanced analytics to improve productivity and reduce deviations in production processes

Electric vehicle makers in talks with Centre on battery decoupling policy

The EV industry seems to be geared up for the change